Invacare Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Invacare.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Medical Equipment earnings growth | 16.2% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
Recent updates
Invacare falls on bankruptcy filing
Feb 01Invacare announces additional draw of $5.5M term loans
Dec 27Invacare Corporation (NYSE:IVC) Analysts Just Slashed Next Year's Estimates
Nov 14Invacare GAAP EPS of -$0.92, revenue of $170.4M
Nov 07Invacare receives non-compliance letter from NYSE
Sep 29Invacare names Geoffrey Purtill as interim president and executive chief
Aug 29Invacare adds two new directors after deal with largest investor Azurite
Aug 23Returns Are Gaining Momentum At Invacare (NYSE:IVC)
Apr 30Invacare (NYSE:IVC) Use Of Debt Could Be Considered Risky
Jan 27Returns On Capital Are Showing Encouraging Signs At Invacare (NYSE:IVC)
Dec 01Here's Why Invacare (NYSE:IVC) Is Weighed Down By Its Debt Load
Sep 30When Should You Buy Invacare Corporation (NYSE:IVC)?
Aug 06Increases to CEO Compensation Might Be Put On Hold For Now at Invacare Corporation (NYSE:IVC)
May 14Invacare EPS misses by $0.02, misses on revenue
May 05Returns On Capital Are Showing Encouraging Signs At Invacare (NYSE:IVC)
May 03Invacare Corporation's (NYSE:IVC) Path To Profitability
Mar 03Invacare (NYSE:IVC) Has A Somewhat Strained Balance Sheet
Feb 05What Can The Trends At Invacare (NYSE:IVC) Tell Us About Their Returns?
Jan 10Invacare's(NYSE:IVC) Share Price Is Down 48% Over The Past Five Years.
Dec 14Invacare Corporation's (NYSE:IVC) Shift From Loss To Profit
Nov 23Invacare Corporation 2020 Q3 - Results - Earnings Call Presentation
Oct 30In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Invacare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2022 | 742 | -101 | -59 | -55 | N/A |
9/30/2022 | 787 | -79 | -31 | -24 | N/A |
6/30/2022 | 840 | -67 | -17 | -5 | N/A |
3/31/2022 | 877 | -56 | -44 | -28 | N/A |
12/31/2021 | 872 | -46 | -32 | -14 | N/A |
9/30/2021 | 870 | -53 | -36 | -16 | N/A |
6/30/2021 | 858 | -37 | -31 | -11 | N/A |
3/31/2021 | 828 | -43 | -6 | 18 | N/A |
12/31/2020 | 851 | -28 | 0 | 22 | N/A |
9/30/2020 | 860 | -42 | -12 | 8 | N/A |
6/30/2020 | 883 | -43 | 2 | 19 | N/A |
3/31/2020 | 923 | -39 | 4 | 15 | N/A |
12/31/2019 | 928 | -53 | -8 | 3 | N/A |
9/30/2019 | 940 | -36 | -11 | -2 | N/A |
6/30/2019 | 948 | -40 | -29 | -19 | N/A |
3/31/2019 | 959 | -44 | -54 | -44 | N/A |
12/31/2018 | 972 | -44 | -56 | -46 | N/A |
9/30/2018 | 978 | -60 | -37 | -22 | N/A |
6/30/2018 | 984 | -67 | -36 | -22 | N/A |
3/31/2018 | 972 | -74 | -34 | -20 | N/A |
12/31/2017 | 966 | -77 | -40 | -26 | N/A |
9/30/2017 | 963 | -77 | -71 | -61 | N/A |
6/30/2017 | 980 | -63 | -65 | -53 | N/A |
3/31/2017 | 1,022 | -51 | -60 | -48 | N/A |
12/31/2016 | 1,047 | -43 | -67 | -57 | N/A |
9/30/2016 | 1,084 | -28 | N/A | -19 | N/A |
6/30/2016 | 1,100 | -31 | N/A | -24 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if IVCR.Q's forecast earnings growth is above the savings rate (2.1%).
Earnings vs Market: Insufficient data to determine if IVCR.Q's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if IVCR.Q's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if IVCR.Q's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if IVCR.Q's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if IVCR.Q's Return on Equity is forecast to be high in 3 years time